These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12428903)

  • 1. PEG-immunoliposome.
    Maruyama K
    Biosci Rep; 2002 Apr; 22(2):251-66. PubMed ID: 12428903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo targeting by liposomes.
    Maruyama K
    Biol Pharm Bull; 2000 Jul; 23(7):791-9. PubMed ID: 10919354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
    Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M
    Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possibility of active targeting to tumor tissues with liposomes.
    Maruyama K; Ishida O; Takizawa T; Moribe K
    Adv Drug Deliv Rev; 1999 Nov; 40(1-2):89-102. PubMed ID: 10837782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo.
    Maruyama K; Takahashi N; Tagawa T; Nagaike K; Iwatsuru M
    FEBS Lett; 1997 Aug; 413(1):177-80. PubMed ID: 9287139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes.
    Uyama I; Kumai K; Yasuda T; Tagawa T; Ishibiki K; Kitajima M; Tadakuma T
    Jpn J Cancer Res; 1994 Apr; 85(4):434-40. PubMed ID: 8200855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of in vivo immunoliposome targeting to pulmonary endothelium.
    Maruyama K; Holmberg E; Kennel SJ; Klibanov A; Torchilin VP; Huang L
    J Pharm Sci; 1990 Nov; 79(11):978-84. PubMed ID: 2292774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of anti-EGFR-Fab' conjugated immunoliposomes modified with two different conjugation linkers for siRNa delivery in SMMC-7721 cells.
    Deng L; Zhang Y; Ma L; Jing X; Ke X; Lian J; Zhao Q; Yan B; Zhang J; Yao J; Chen J
    Int J Nanomedicine; 2013; 8():3271-83. PubMed ID: 24023515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals].
    Zhang YF; Xie SS; Hou XP; Gao X; Zhang S; Chen ZS
    Yao Xue Xue Bao; 2000 Nov; 35(11):854-9. PubMed ID: 11218866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo.
    Ishida O; Maruyama K; Tanahashi H; Iwatsuru M; Sasaki K; Eriguchi M; Yanagie H
    Pharm Res; 2001 Jul; 18(7):1042-8. PubMed ID: 11496943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells.
    Mamot C; Ritschard R; Küng W; Park JW; Herrmann R; Rochlitz CF
    J Drug Target; 2006 May; 14(4):215-23. PubMed ID: 16777680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific Conjugation of the Hinge Region for Homogeneous Preparation of Antibody Fragment-Drug Conjugate: A Case Study for Doxorubicin-PEG-anti-CD20 Fab' Synthesis.
    Zhou Z; Zhang J; Zhang Y; Ma G; Su Z
    Bioconjug Chem; 2016 Jan; 27(1):238-46. PubMed ID: 26700095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
    Maruyama K; Kennel SJ; Huang L
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution of immunoliposome labeled with Tc-99m in tumor xenografted mice.
    Kitamura N; Shigematsu N; Nakahara T; Kanoh M; Hashimoto J; Kunieda E; Kubo A
    Ann Nucl Med; 2009 Feb; 23(2):149-53. PubMed ID: 19225938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW; Allen TM
    J Control Release; 2008 Feb; 126(1):50-8. PubMed ID: 18068849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.
    Mori A; Kennel SJ; van Borssum Waalkes M; Scherphof GL; Huang L
    Cancer Chemother Pharmacol; 1995; 35(6):447-56. PubMed ID: 7882453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-GAD antibody targeted non-viral gene delivery to islet beta cells.
    Jeong JH; Lee M; Kim WJ; Yockman JW; Park TG; Kim YH; Kim SW
    J Control Release; 2005 Oct; 107(3):562-70. PubMed ID: 16139384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation.
    Patil HP; Freches D; Karmani L; Duncan GA; Ucakar B; Suk JS; Hanes J; Gallez B; Vanbever R
    J Control Release; 2018 Feb; 272():62-71. PubMed ID: 29247664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.